Sleep Apnea, Central
Welcome,         Profile    Billing    Logout  
 1 Company   0 Products   0 Products   1 Mechanism of Action   0 Trials   17 News 
  • ||||||||||  Trial primary completion date:  Respicardia, Inc. Pivotal Trial of the remedē System (clinicaltrials.gov) -  Apr 15, 2016   
    P=N/A,  N=173, Active, not recruiting, 
    Active, not recruiting --> Completed Trial primary completion date: Feb 2016 --> Oct 2016
  • ||||||||||  Trial completion, Trial primary completion date:  Seattle-PAP Bubble Nasal CPAP and Work of Breathing (clinicaltrials.gov) -  Apr 14, 2016   
    P1,  N=40, Completed, 
    Trial primary completion date: Feb 2016 --> Oct 2016 Recruiting --> Completed | Trial primary completion date: Dec 2014 --> Oct 2015
  • ||||||||||  acetazolamide / Generic mfg.
    Enrollment change:  Buspirone as a Potential Treatment for Recurrent Central Apnea (clinicaltrials.gov) -  Mar 15, 2016   
    P3,  N=8, Terminated, 
    Recruiting --> Completed | Trial primary completion date: Dec 2014 --> Oct 2015 N=28 --> 8
  • ||||||||||  Enrollment change, Trial withdrawal:  Eval EarlySense Bet Lowenstein Sleeplab (clinicaltrials.gov) -  Dec 15, 2015   
    P=N/A,  N=0, Withdrawn, 
    N=28 --> 8 N=100 --> 0 | Not yet recruiting --> Withdrawn
  • ||||||||||  Enrollment closed:  Respicardia, Inc. Pivotal Trial of the remedē System (clinicaltrials.gov) -  Jun 4, 2015   
    P=N/A,  N=173, Active, not recruiting, 
    Recruiting --> Completed | Trial primary completion date: Jan 2016 --> Apr 2015 Recruiting --> Active, not recruiting
  • ||||||||||  Trial primary completion date:  Respicardia, Inc. Pivotal Trial of the remedē System (clinicaltrials.gov) -  Apr 19, 2015   
    P=N/A,  N=173, Recruiting, 
    Recruiting --> Active, not recruiting Trial primary completion date: Mar 2015 --> Feb 2016
  • ||||||||||  desogestrel / Generic mfg.
    Enrollment change:  RESPIRONDINE: Assessment of Desogestrel in Ondine Syndrome (clinicaltrials.gov) -  Nov 12, 2013   
    P2/3,  N=6, Completed, 
    Trial primary completion date: Sep 2014 --> Jan 2016 N=12 --> 6
  • ||||||||||  acetazolamide / Generic mfg.
    Trial termination:  Buspirone as a Potential Treatment for Recurrent Central Apnea (clinicaltrials.gov) -  Sep 25, 2011   
    P3,  N=28, Terminated, 
    Not yet recruiting --> Recruiting Recruiting --> Terminated; Patient recruitment and Funding inadequate to finish trial